Ligand Pharmaceuticals (LGND) Restructuring Costs (2010 - 2016)
Ligand Pharmaceuticals (LGND) reported Restructuring Costs of $374000.0 for Q2 2016, up 71.56% on a YoY basis from $218000.0 in Q3 2015, and up 53.28% sequentially from $244000.0 in Q1 2016.
Ligand Pharmaceuticals (LGND) Restructuring Costs (2010 - 2016) Analysis & Trends
Ligand Pharmaceuticals (LGND) has 7 years of Restructuring Costs data on file, last reported at $374000.0 in Q2 2016.
- For the quarter ending Q2 2016, Restructuring Costs rose 71.56% year-over-year to $374000.0; the trailing twelve-month figure through Jun 2016 stood at $1.2 million (up 1.01% YoY), and the FY2016 full-year result was $1.0 million, up 1.18% from the prior year.
- Restructuring Costs improved to $374000.0 in Q2 2016, from $244000.0 in the prior quarter.
- In the past five years, Restructuring Costs ranged from a high of $562000.0 in Q4 2014 to a low of $44000.0 in Q2 2013.
- A 5-year average of $239111.1 and a median of $220500.0 in 2015 frame the typical range for Restructuring Costs.
- Across the five-year window, Restructuring Costs surged 8300.0% in 2012 and sank 89.37% in 2013, its largest moves.
- Tracing LGND's Restructuring Costs over 5 years: stood at $356000.0 in 2012, then plunged by 43.54% to $201000.0 in 2013, then soared by 179.6% to $562000.0 in 2014, then tumbled by 58.36% to $234000.0 in 2015, then surged by 59.83% to $374000.0 in 2016.
- Business Quant data shows LGND's Restructuring Costs at $374000.0 in Q2 2016, $244000.0 in Q1 2016, and $234000.0 in Q4 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Ligand Pharmaceuticals | 6.05 Bn | 5.27 Bn | 48.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2016 | 374,000.00 |
| Mar 31, 2016 | 244,000.00 |
| Dec 31, 2015 | 234,000.00 |
| Sep 30, 2015 | 345,000.00 |
| Jun 30, 2015 | 218,000.00 |
| Mar 31, 2015 | 223,000.00 |
| Dec 31, 2014 | 562,000.00 |
| Sep 30, 2014 | 182,000.00 |
| Jun 30, 2014 | 136,000.00 |
| Mar 31, 2014 | 204,000.00 |
| Dec 31, 2013 | 201,000.00 |
| Sep 30, 2013 | 227,000.00 |
| Jun 30, 2013 | 44,000.00 |
| Mar 31, 2013 | 89,000.00 |
| Dec 31, 2012 | 356,000.00 |
| Sep 30, 2012 | 164,000.00 |
| Jun 30, 2012 | 414,000.00 |
| Mar 31, 2012 | 87,000.00 |
| Dec 31, 2011 | 720,000.00 |
| Sep 30, 2011 | -2,000.00 |